- Home
- FMST vs SNTI Comparison
FMST vs SNTI Comparison
Compare FMST & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- SNTI
- Stock Information
- Founded
- FMST 2005
- SNTI 2016
- Country
- FMST Canada
- SNTI United States
- Employees
- FMST N/A
- SNTI N/A
- Industry
- FMST Other Metals and Minerals
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- FMST Basic Materials
- SNTI Health Care
- Exchange
- FMST Nasdaq
- SNTI Nasdaq
- Market Cap
- FMST 38.2M
- SNTI 39.6M
- IPO Year
- FMST N/A
- SNTI N/A
- Fundamental
- Price
- FMST $3.95
- SNTI $2.21
- Analyst Decision
- FMST
- SNTI Strong Buy
- Analyst Count
- FMST 0
- SNTI 3
- Target Price
- FMST N/A
- SNTI $9.67
- AVG Volume (30 Days)
- FMST 748.1K
- SNTI 330.2K
- Earning Date
- FMST 11-21-2025
- SNTI 11-13-2025
- Dividend Yield
- FMST N/A
- SNTI N/A
- EPS Growth
- FMST N/A
- SNTI N/A
- EPS
- FMST N/A
- SNTI N/A
- Revenue
- FMST N/A
- SNTI N/A
- Revenue This Year
- FMST N/A
- SNTI N/A
- Revenue Next Year
- FMST N/A
- SNTI $150.00
- P/E Ratio
- FMST N/A
- SNTI N/A
- Revenue Growth
- FMST N/A
- SNTI N/A
- 52 Week Low
- FMST $0.55
- SNTI $1.26
- 52 Week High
- FMST $5.74
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- FMST 59.40
- SNTI 70.48
- Support Level
- FMST $3.43
- SNTI $2.07
- Resistance Level
- FMST $4.57
- SNTI $2.55
- Average True Range (ATR)
- FMST 0.39
- SNTI 0.23
- MACD
- FMST 0.05
- SNTI 0.07
- Stochastic Oscillator
- FMST 62.84
- SNTI 70.17
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.